Zhiyang Zhao received his Ph.D.
degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia under
supervision of Professor Neal Castagnoli, Jr.
His biotechnology/pharmaceutical work experience encompasses
17-years of research on metabolic and pharmacokinetic properties of compounds
for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen.
вЂњZhao,вЂќ as he is known by friends and colleagues, currently
serves as Director of Preclinical at AmgenвЂ™s Research & Development
site located in Cambridge, Massachusetts. He spent the last 3 years recruiting,
establishing, and organizing the formation of the Pharmacokinetics &
Drug Metabolism department and managing its preclinical support processes.
He has provided supervisory and hands-on expertise in drug
metabolism and pharmacokinetic studies for discovery and development projects
with experience in integration of in vitro and in vivo ADMET information
to optimize drug candidate properties.
His accomplishment is documented via his contributions
as lead and co-author of over forty patents and peer reviewed publications
in the areas of new drug targets, drug metabolism, pharmacokinetics, and
toxicology. He is currently serving as the 2008 APA Chair, Biotransformation.